
Validea's guru fundamental report indicates Humana (HUM), a large-cap healthcare facilities stock, received a 70% rating from Meb Faber's Shareholder Yield Investor model. This model prioritizes companies returning cash to shareholders via dividends, buybacks, and debt paydown; however, despite passing quality, valuation, and relative strength criteria, HUM notably failed the specific 'Net Payout Yield' and 'Shareholder Yield' tests, placing it below the 80% threshold for 'some interest' within the strategy.
According to a Validea fundamental report, Humana Inc. (HUM), a large-cap growth stock in the healthcare facilities sector, scored 70% based on Meb Faber's Shareholder Yield Investor model. This score is below the 80% threshold that typically indicates strategic interest. The analysis presents a notable conflict: while HUM passed the model's criteria for 'Quality and Debt', 'Valuation', and 'Relative Strength', it specifically failed on the core tenets of the strategy, namely 'Net Payout Yield' and 'Shareholder Yield'. This suggests that while the company exhibits positive underlying fundamentals and favorable valuation, its current capital return program—comprising dividends, share buybacks, and debt reduction—does not meet the specific, aggressive benchmarks required by this particular investment model. The resulting mixed sentiment signal accurately reflects this dichotomy between general financial health and a specific weakness in shareholder-return metrics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
-0.10
Ticker Sentiment